Cardiac glycoside bufalin blocks cancer cell growth by inhibition of Aurora A and Aurora B activation via PI3K-Akt pathway

In our previous study, cardiac glycosides including bufalin, a group of sodium pump (Na+/K+-ATPase) inhibitors widely used to treat heart failure for many years, have been demonstrated to induce a delay of mitotic entry and mitotic arrest in many cancer cells. However, the underlying mechanism remai...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Xie, Chuan-Ming, Lin, Xiao-Tong, Wu, Di, Tan, Ye, Cheng, Christopher H.K., Zhang, Jun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2018
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5862615/
https://ncbi.nlm.nih.gov/pubmed/29568394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24475
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk